News & Analysis on Clinical Trial Services & Contract Research And Development
A study in the Journal of the American Medical Association (JAMA) claiming there is no evidence that brandname cardiovascular drugs are superior to their generic counterparts, despite claims to the contrary.
The latest research into the delivery of heparin was on display at this year’s AAPS, demonstrating the work that has been undertaken to improve administration methods.
Pantec Biosolutions has received CE marking for its painless laser epidermal system (P.L.E.A.S.E.), which it claims can facilitate transdermal delivery of high molecular weight drugs.
Qatar and Egypt are to set up a new drug manufacturing plant at a facility in Qatar, according to BusinessIntelligence. The new facility will begin by producing soluble drugs for the emerging Qatari and Egyptian drug markets.
Icelandic generics firm Actavis plans to use Malta as a distribution hub for the supply of drugs to the emerging African pharmaceutical market, according to reports in the Maltese press.
UK drug giant GSK is to shed 200 jobs at its manufacturing plant in Barnard Castle, County Durham to cut costs ahead of generic competition for products made at the facility, which include the anti-emetic Zofran (ondansentron).